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CASE REPORT
Intra-Abdominal Desmoplastic Small Round
Cell Tumorc
Jaimie D. Nathana, Cynthia Gingalewski, and Ronald R. Salem
Department ofSurgery, Yale University School ofMedicine, New Haven, Connecticut
Background: Intra-abdominal desmoplastic small round cell tumor is a rare malignancy with a
predilectionforyoung males. Unique histological and immunocytochemicalfeatures distinguish the
tumorfrom other members ofthefamily ofsmall round cell tumors ofinfancy and childhood. The
aggressive nature oftumor spread, relative insensitivity to chemotherapy, and generally incomplete
resectability result in a very poorprognosis. The authors report a case ofa 39-year-old man with
diffuse abdominal andpelvic involvement ofintra-abdominal desmoplastic small round cell tumor
treated with aggressive chemotherapy and surgery.
Methods: Computed tomography (CT)-guided biopsy of an omental mass was performed.
Histologically, discrete nests ofuniform closelypacked malignant cells were distributed in a back-
ground offocally desmoplastic stroma. Immunocytochemistry demonstratedpositivityforepithelial,
mesenchymal, and neural markers. On the basis of these unique histological and immunohisto-
chemical characteristics, the diagnosis of desmoplastic small round cell tumor was made. The
patient was treated with aggressive neoadjuvant chemotherapy consisting ofa high-dose alkylator
-based combination regimen, followed by surgery.
Results: Thepatient had a 10 to 15 percent regression in tumor mass in response to chemotherapy.
Laparotomy revealed two large omental masses, another large mass adherent to the left colon and
pelvic sidewall, and diaphragmatic, peritoneal and mesenteric studding with small nodules.
Complete surgical resection was notpossible.
Conclusions: Intra-abdominal desmoplastic small round cell tumor remains an aggressive malig-
nancy with an extremely poor prognosis. Although some response to chemotherapy may be possi-
ble, complete resection is rare, and surgical efforts are generallypalliative.
INTRODUCTION
First described in 1987 by Sesterhenn
et al. [1], intra-abdominal desmoplastic
small round cell tumor (IADSRCT)b is a
distinct variant of the small round cell
tumors of infancy and childhood. It is an
uncommon, highly aggressive tumor with
a predilection for young males [2-15].
Predominantly intra-abdominal in location,
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684-81 1 1; Fax: 919-681-7934; E-mail: nathaOO2@?mc.duke.edu.
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IADSRCT lacks a visceral site of origin
and spreads diffusely along serosal sur-
faces. Histologically, this tumor is charac-
terized by well-demarcated nests oftumor
cells surrounded by an abundant desmo-
plastic stroma. Co-expression ofepithelial,
mesenchymal and neural markers is a
unique feature of IADSRCT [2-6, 9, 16],
as is its association with a characteristic
chromosomal translocation t(11;12)
(pl3;qll.2 or q12) [17-20]. Prognosis is
uniformly poor because the malignancy is
relatively insensitive to chemotherapy and
radiation, and surgical excision is rarely
complete. Due to the rarity of this malig-
nancy, optimal treatment regimens have
yet to be defined. We report the case of a
39-year-old man with diffuse abdominal
and pelvic involvement ofintra-abdominal
desmoplastic small round cell tumor treat-
ed with aggressive neoadjuvant
chemotherapy and surgery.
CASE HISTORY
A 39-year-old white man, previously
well, presented to his primary care physi-
cian with a six-week history of left lower
quadrant abdominal discomfort, early sati-
ety, increasing abdominal girth, rectal
pressure during bowel movements,
decreased caliber of bowel movements,
intermittent night sweats and lower back
discomfort, as well as a 12-pound weight
loss.
On physical examination, the
abdomen was moderately distended with
ascites, and two large, firm, nontender,
mobile masses were palpable in both
lower abdominal quadrants. Laboratory
studies were unremarkable except for lac-
tate dehydrogenase 287 u/l (normal 50-
240 u/l). Computed tomography (CT)
scan revealed an extensive soft tissue
mass filling the pelvis and displacing the
rectum posteriorly, as well as severe
ascites and evidence ofperitoneal carcino-
matosis with multiple large solid masses
involving the omentum and the bowel
wall (Figure 1). CT-guided biopsy of an
omental mass was consistent with desmo-
plastic small round cell tumor.
Neoadjuvant chemotherapy was be-
gun with intravenous cyclophosphamide,
doxorubicin, and vincristine, alternating
with ifosfamide and etoposide. The patient
responded clinically to the first three
* --j ij Figure 1. Pre-chemotherapy
contrast-enhanced CT scan
of the abdomen. Large bulky
intraperitoneal soft tissue
masses (M) are noted displac-
ing bowel loops. Severe
ascites (A) and peritoneal nod-
ules (arrows) are also evident.Nathan etal.: Intra-abdominal small cell tumor 15
cycles of chemotherapy, requiring para-
centesis less frequently. Subsequent CT
scan revealed a 10 to 15 percentregression
in tumor mass. The patient underwent two
additional courses of chemotherapy after
which he required stem cell rescue. CT
scan showed no further change in tumor
mass.
At laparotomy, 2.5 liters of ascites
was found within the peritoneal cavity.
Two large mobile masses were found
attached to the greater omentum, with
tumor very closely adherent to the splenic
flexure. Athird large mass was attached to
the left pelvic sidewall and to the sigmoid
colon and extended between the bladder
and the rectum. The diaphragm was stud-
ded with small nodules, and tumornodules
were noted throughout the mesentery and
parietal peritoneum. The tumor was mobi-
lized from the splenic flexure and from the
sigmoid colon, bladder and rectum and
was transected at its attachment to the left
pelvic side wall, allowing en bloc resec-
tion ofthe three masses and the omentum.
The parietal peritoneum was removed
with electrocautery, and the nodules with-
in the small bowel mesentery were maxi-
mally resected. Post-operative course has
been uneventful, and subsequenttherapeu-
tic efforts will include radiation and fur-
ther chemotherapy.
PATHOLOGY
Macroscopic findings
The 2,000-gm specimen consisted of
omentum studded with numerous tumor
nodules ofvariable size, some distinct and
spherical and others confluent. The speci-
men measured 20 cm x 20 cm x 11 cm as
a whole, with tumor nodules ranging from
0.5 cm to 16 cm in size. The tumor was
firm and smooth, and the cut surface ofthe
nodules revealed firm, white densely
fibrotic areas alternating with soft, gelati-
nous myxoid areas.
Histological findings
The specimen obtained by CT-guided
biopsy was characterized by discrete nests
of uniform closely packed malignant cells
distributed in a background of focally
desmoplastic stroma (Figure 2). The nests
of cells varied in appearance from irregu-
lar islands to narrow cords and infiltrating
strands. The tumor cells were small, with
hyperchromatic round to oval nuclei, scant
eosinophilic cytoplasm and indistinct
cytoplasmic borders. Nucleoli were gener-
ally inconspicuous. Mitotic figures were
rare, and anaplastic nuclei were not pre-
sent. Tubular orglandular foci, rosettes, or
other recognizable signs of differentiation
were absent. The stroma was dense and
collagenous with occasional scattered
spindle-shaped fibroblast-like cells. The
tumor predominantly consisted of malig-
nant cells, with the stromal component
occupying a smaller portion of the speci-
men. In addition to the characteristics of
the biopsy specimen, the resected speci-
men revealed cystic changes and some
myxoid areas within the stroma.
Immunohistochemistry
On immunohistochemical staining,
the neoplastic cells were strongly positive
for the epithelial marker keratin (AEl/AE3
and CAM 5.2), diff-usely throughout the
cytoplasm. Although positivity for epithe-
lial membrane antigen (EMA) was also
strong, its distribution was more patchy
than that of keratin. Reactions with anti-
vimentin antibody revealed diffuse cyto-
plasmic positivity in the majority oftumor
cells, while staining with desmin was spo-
radically positive and showed a paranu-
clear cytoplasmic "dot-like" or "globoid"
pattern of expression. The tumor cells
demonstrated focal positivity for alpha-16 Nathan et al.: Intra-abdominal small cell tumor
smooth muscle actin (Figure 3). Staining
for neuron-specific enolase (NSE) and S-
100 protein, markers ofneural differentia-
tion, exhibited a focal pattern ofpositivity
(Figure 4).
DISCUSSION
IADSRCT is a recently described
entity belonging to the category of small
round cell tumors of infancy and child-
hood, including Ewing's sarcoma, primi-
tive neuroectodermal tumor, embryonal or
alveolar rhabdomyosarcoma, neuroblas-
toma, malignant lymphoma, Askin's
tumor, and rhabdoid tumor. This group of
neoplasms is characterized by small uni-
form cells with sparse cytoplasm, diffuse
growth pattern, and high cellularity.
Specific clinical, topographical, mor-
phological and immunohistochemical fea-
tures, however, differentiate IADSRCT
from other members of its family.
Although not as marked as reported in the
first series ofIADSRCTby Gerald et al. in
1991 [3], the male predominance of this
tumor has been described in several subse-
quent reviews (male-to-female ratio,
greater than 3:1) [8, 21-23]. Adolescents
and young adults are typically affected,
with a mean age between 18 and 20 years
(range 3 to 48) [23], and greater than 70
percent of patients present before the age
of thirty in reviews of larger series [3, 21,
22]. The most common presenting symp-
toms ofIADSRCT are abdominal pain and
distention, related to enlarging tumor bur-
den and sometimes to ascites, as in our
case. The tumor tends to arise intra-
abdominally on serosal surfaces without
an obvious visceral primary site. A domi-
nant omental or pelvic mass is common
with multiple surrounding smaller satellite
nodules adherent to the peritoneum.
Grossly, the tumor is firm, smooth and
bosselated, with a gray-white cut surface
and focal necrotic and hemorrhagic
regions [2-4].
Histologically, IADSRCT is charac-
terized by well-defined nests or strands of
uniform small round tumorcells surround-
ed by an abundant desmoplastic stroma.
Generally, morphologic signs of differen-
tiation are absent. However, tubular lumi-
na have been noted in pathologic speci-
mens of IADSRCT [2], and glandular and
neural components have, likewise, been
reported [4, 16, 21, 22]. Although the
malignant cells and the stromal compo-
nent usually occupy equal proportions of
the tumor, the stroma in IADSRCT can be
highly variable, with some tumors being
predominantly cellularand others predom-
inantly stromal [2, 21, 23]. Within the
dense collagen-rich stroma, spindle cells
resembling fibroblasts or myofibroblasts
can be identified. The stroma may consist
of myxoid areas, cystic degeneration and
calcification [21]. In our case, the CT-
guided biopsy specimen did not reveal
these components, suggesting that the
myxoid areas and cystic changes found in
the resected specimen may have been
associated with the neoadjuvant chemo-
therapy received. Alternatively, tumor het-
erogeneity may account for the histologi-
cal differences.
Although the clinical and histological
features of IADSRCT may be sufficiently
distinctive to suggest its diagnosis, IAD-
SRCT is most easily distinguished from
other members of its family by the unique
immunoreactivity for epithelial, mes-
enchymal and neural markers. Immuno-
positivity forkeratin andEMA, markers of
epithelial differentiation, is usually diffuse
throughout the cytoplasm and widespread.
Some reports have demonstrated, howev-
er, that EMA reactivity is variable, with
patchy or scattered distribution and local-
ization adjacent to the cytoplasmic mem-
branes [6, 24]. The mesenchymal markers,
vimentin and desmin, are consistently
expressed in IADSRCT. Vimentin usuallyNathan et al.: Intra-abdominal small cell tumor
Figure 2. Histologic appearance
of tumor.The tumor is composed of
irregular islands and cords of malig-
nant cells that are oval and spindle-
shaped with scanty cytoplasm and
dark ovoid to round nuclei. Islands
and cords of tumor cells are sepa-
rated by a dense desmoplastic stro-
ma containing occasional spindle-
shaped cells. (H & E, x 250).
Figure 3. Immunostaining for
smooth muscle actin. Focal
cytoplasmic immunopositivity for
SMA is present in many tumor
cells. (Immunoperoxidase, x 400).
Figure 4. Immunostaining for
S-100 protein. The tumor cells
show focally positive cytoplas-
mic immunohistochemical
staining for S-100 protein, a
marker of neural differentiation.
(Immunoperoxidase, x 400).
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exhibits widespread, diffuse cytoplasmic
staining, while desmin positivity has a
classic paranuclear "dot-like" or "globoid"
pattern, though a diffuse, cytoplasmic
quality has been noted [16, 22]. Despite
immunoreactivity for keratin, EMA and
desmin, microscopic features of epithelial
or myoid differentiation are generally
absent. In our case, neoplastic cells were
focally positive for alpha-smooth muscle
actin, an uncommonly expressed antigen
in IADSRCT [22]. Although neurosecreto-
ry dense-core granules, ultrastructural evi-
dence of neuroendocrine differentiation,
have been reported only rarely [3, 4, 16],
IADSRCT is usually immunopositive for
NSE and occasionally expresses S-100
protein as well [16, 21, 25]. Co-expression
of epithelial, mesenchymal, and neural
antigens in the same cell suggests that
IADSRCT may arise during development
from a primitive pluripotential stem cell.
However, the histogenesis of IADSRCT
remains unknown.
Evidence demonstrating the associa-
tion of a specific chromosomal abnormali-
ty with some cases ofIADSRCT may pro-
vide insight into the histogenesis of this
tumor at a molecular level. In most cases
analyzed cytogenetically, the genetic alter-
ation involves a unique reciprocal translo-
cation, t(11;12)(pl3;qll.2 or q12), and is
not the same 11;12 translocation found in
other small round cell tumors, giving fur-
ther support to the notion that IADSRCT is
a distinct, yet related, tumor type [17-20].
The breakpoint loci involve the chromoso-
mal regions of the Ewing's sarcoma gene
(EWS) and the Wilms' tumor suppressor
gene (WTI), whichhavebeenimplicated in
other malignant developmental neoplasms
[26, 27]. Recent studies have demonstrated
evidence of expression of chimeric EWS-
WTI RNAin IADSRCT resulting from the
fusion ofthe EWS and WTI genes [28]. As
suggested by Parkash et al. [29], the diver-
gent differentiation of IADSRCT may be
theresult oftheEWS-WTI fusion, allowing
a combination of neural differentiation of
Ewing's neoplasms with the multidirec-
tional differentiation of Wilms' tumors.
Although chromosomal analysis has been
conducted in only a small number ofcases,
the t(ll;12)(pl3;qll.2 or q12) appears to be
a specific alteration and may prove useful
in the elucidation of the molecular patho-
genesis of IADSRCT and perhaps in the
molecular diagnosis ofthe tumor.
The diagnosis ofIADSRCT is usually
not made until tissue is obtained at laparo-
tomy, thereby precluding the use ofneoad-
juvant therapy. In our case, diagnosis was
made by CT-guided biopsy, with obvious
therapeutic consequences. In 1992,
Setrakian et al. [30] described the case of
a 20-year-old man with a subhepatic soft
tissue mass biopsied by CT-guided fine
needle aspiration. Cytologic analysis
revealed small round cells with scarce
cytoplasm and occasional fibroblast-like
cells, andimmunostaining was positive for
cytokeratin, desmin and NSE, confirming
the diagnosis of IADSRCT. The specifici-
ty ofimmunopositivity for epithelial, mes-
enchymal and neural markers makes CT-
guided fine needle aspiration a very useful
technique in the diagnosis ofIADSRCT.
IADSRCT exhibits an extremely
aggressive clinical course and in general,
carries a very poor prognosis. Although a
standardized treatment protocol is lacking,
several studies have attempted to define
the biological behavior ofthe tumor and its
response to various therapeutic modalities.
In the series by Gerald et al. [3] in 1991, 19
patients underwent surgical "debulking,"
followed in most cases by multi-drug
chemotherapy with or without irradiation.
Generally, an incomplete surgical resec-
tion and partial response to chemotherapy
was followed by rapid, uncontrollable
relapse. In 1993, Ordonez et al. [22] like-
wise reported only rare complete surgical
resection but initial tumor reduction with
adjuvant multi-agent chemotherapy.
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was the rule. With evidence in these stud-
ies of some degree of chemosensitivity in
these tumors, Farhat et al. [31] described
four patients with IADSRCT who were
treated with an adjuvant cisplatin-based
multi-drug regimen following suboptimal
surgical debulking or biopsy. All four
patients demonstrated stable disease after
four to nine courses ofchemotherapy. In a
prospective study by Kushner et al. [9] in
1996, five of eight previously untreated
patients experienced complete remission
following a high-dose neoadjuvant alkyla-
tor-based regimen and surgical resection.
Another two patients had complete surgi-
cal resection at the time of diagnosis and
were in complete remission following
adjuvant chemotherapy. With or without
consolidative radiotherapy and/or mye-
loablative chemotherapy, five of the seven
patients remained in complete remission
10 to 39 months from the start ofthe alky-
lator-based regimen, demonstrating that
progression-free survival of prolonged
duration is attainable. In Amato et al. [7],
four of five patients treated with various
multi-agent chemotherapeutic regimens
with or without surgical intervention had
evidence of a partial response but eventu-
ally died from their disease within 3.5
years from diagnosis. Treated with a regi-
men similar to that described by Kushner
et al., our patient had an apparent clinical
response to therapy, but CT scan demon-
strated only a 10 to 15 percent reduction in
tumor mass, and complete surgical resec-
tion was not possible. Adjuvant therapy
will include irradiation and additional
chemotherapy.
IADSRCT remains an aggressive
malignancy with an extremely poor prog-
nosis. Although some response to chemo-
therapy may be possible, in particular to
high-dose alkylator-based regimens, com-
plete surgical resection is rare, and despite
aggressive therapy, survival rates remain
low due to the refractory nature of the
tumor. Additional studies are necessary to
further elucidate the biology ofthe disease
and to optimize treatment regimens.
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